Concepedia

Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis

Klaas Vandenbroucke, Hans de Haard, Els Beirnaert, Torsten Dreier, Marc Lauwereys, Lynn Huyck, Jacques Van Huysse, Pieter Demetter, Lothar Steidler, E. Remaut,

Mucosal Immunology · 2009 · 284 citations · 37 references

DOIFull text

Open access

Concepts

References

37

Interleukin-10-deficient mice develop chronic enterocolitis

Ralf Kühn, Jürgen Löhler, D Rennick et al. · Cell · 1993 · 4.3K citations

, , +14

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations

, , +12

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text

, , +14

Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

Joseph Keane, Sharon K. Gershon, Robert P. Wise et al. · New England Journal of Medicine · 2001 · 3.7K citations · Full text

, , +16

Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker

Peter P. Bradley, Dennis A. Priebat, Robert D. Christensen et al. · Journal of Investigative Dermatology · 1982 · 3.6K citations · Full text

, , +16